노보텍, 중국 내 종양학 임상 가속화 관련 2022년 엔드포인트 ASCO 전문가 패널 후원
Jun 07, 2022 20:00 HKT |  |
|
华领医药在2022ADA科学年会公布多格列艾汀能够明显改善2型糖尿病患者和GCK-MODY患者的胰岛素早相分泌和葡萄糖敏感性
Jun 07, 2022 10:17 HKT |  |
|
華領醫藥在2022ADA科學年會公佈多格列艾汀能夠明顯改善2型糖尿病患者和GCK-MODY患者的胰島素早相分泌和葡萄糖敏感性
Jun 07, 2022 10:16 HKT | |
|
Hua Medicine Announces Dorzagliatin can Restore Glucose Sensitivity and Early Phase Insulin Secretion in T2DM and GCK-MODY Patients at ADA 2022
Jun 07, 2022 10:15 HKT | |
|
Novotech助力Endpoints ASCO 2022年专家组，加速中国肿瘤临床试验
Jun 07, 2022 08:00 HKT | |
|
Novotech助力Endpoints ASCO 2022年專家組，加速中國腫瘤臨床試驗
Jun 07, 2022 08:00 HKT | |
|
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
Jun 06, 2022 18:00 HKT | |
|
医思健康携手凯龙瑞及亚洲联合基建成立合资公司
Jun 06, 2022 10:37 HKT |  |
|
醫思健康攜手凱龍瑞及亞洲聯合基建成立合資公司
Jun 06, 2022 10:36 HKT | |
|
EC Healthcare Forms a Joint Venture with KaiLong and Asia Allied Infrastructure
Jun 06, 2022 10:35 HKT | |
|
香港中文大学周怡君教授荣获 2022 WIN ADA Award，以表彰其在糖尿病领域的优异研究成果及贡献
Jun 05, 2022 09:09 HKT |  |
|
香港中文大學周怡君教授榮獲 2022 WIN ADA Award，以表彰其在糖尿病領域的優異研究成果及貢獻
Jun 05, 2022 09:08 HKT | |
|
CUHK Professor Elaine Chow Receives "2022 Women's Interprofessional Network of the American Diabetes Association Abstract Award" for Outstanding Research and Care in Diabetes
Jun 05, 2022 09:07 HKT | |
|
노보텍, 초기 단계 종양학 임상 및 미-중 규제 전략에 관한 프리-ASCO 중국 서밋의 전문가 패널들을 후원
Jun 03, 2022 20:00 HKT | |
|
Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组
Jun 03, 2022 07:00 HKT | |
|
Novotech 贊助 ASCO 中國峰會前中美早期腫瘤試驗和監管策略專家組
Jun 03, 2022 07:00 HKT | |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Jun 02, 2022 21:00 HKT |  |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
Jun 02, 2022 21:00 HKT | |
|
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US
Jun 02, 2022 18:00 HKT | |
|
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOT BIOPHARM Shares
Jun 02, 2022 09:37 HKT | |
|